Post

New research · Internal Medicine
Medicina (Kaunas, Lithuania) · 3h
Systematic reviewMedicina (Kaunas, Lithuania) · 2026

Thromboprophylaxis After ACL Reconstruction: Controversies and Future Challenges.

Theodoros Bouras, Panagiotis Antzoulas, Vasileios Giannatos … Vasileios Chouliaras
Read paper
Internal MedicineSystematic review
“

Current evidence does not support universal thromboprophylaxis following anterior cruciate ligament reconstruction. A risk-stratified approach is recommended, with mechanical measures or aspirin for low-to-moderate-risk patients and LMWH or DOACs for high-risk individuals. Future research may focus on genetic and patient-specific factors to better explain existing heterogeneity.

Thromboprophylaxis After ACL Reconstruction: Controversies and Future Challenges.

Theodoros Bouras … Vasileios Chouliaras
Medicina (Kaunas, Lithuania) · 2026
Background

Anterior cruciate ligament reconstruction (anterior cruciate ligament reconstruction) is a very common procedure in young, active individuals.

Purpose

This review aims to summarize key international recommendations to support clinical decision-making.

Methods

Rather than performing a systematic review, relevant documents were identified from official publications, consensus statements, and registry-based recommendations issued by recognized orthopaedic and thrombosis-related organizations.

More results

This narrative review identified nine major international guidelines addressing thromboprophylaxis in anterior cruciate ligament reconstruction.

Most guidelines, including CHEST and NICE, advise against routine anticoagulation for low-risk patients, reserving it for those with specific risk factors.

More results

While ICM-VTE supports the use of aspirin or LMWH in high-risk cases, SFAR stands out by recommending routine LMWH for all patients.

HAOST emphasizes early mobilization and selective prophylaxis, including aspirin for low-risk groups.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
0.8%
an oversedation event needing naloxone reversal was rare
Randomized Trial
t = -4.35
intervention caregivers asked more questions than controls
Cohort Study
67.8%
one-year survival was far worse than the intermediate-risk group's, roughly one in three died
Review
50-100%
rheumatoid arthritis raises blood clot risk well above the general population
Cross-sectional
SIR 9.93
risk climbs sharply when relatives cluster and clotting starts young
Study
82.5%
guideline-recommended anticoagulation reached most hospitalized af patients after screening
Study
7.74
Average knowledge score rose from 5.24 to 7.74 after the education intervention
Cohort Study
34.4%
just over a third stayed safely anticoagulated, most were not